To date, no effective treatment is available for Becker muscular dystrophy (BMD) and sporadic inclusion body myositis (sIBM). However, there is a number of promising therapeutic strategies, which are in preclinical development or have moved into clinical trials. Hence, sensitive and specific tools are required for assessment of possible benefit from new treatments. In this regards muscle MRI has been considered a possible alternative outcome measure in these myopathies, although there is no consensus on what muscle MRI protocol should be performed.

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...